Plasma levels of VEGF-A, VWF:Ag, and ADAMTS13:AC were analyzed in these 22 patients with AMD at 1 day, 1 week, and 1 month after the intravitreal injection of aflibercept. The gene discussed is ADAMTS13; the disease is age-related macular degeneration.